ÐÓ°ÉÂÛ̳

Skip to main content
Quest Diagnostics

Neurological Complications of ÐÓ°ÉÂÛ̳-19

Date: Wednesday, Nov 18, 2020

Description: Presented by Dr. Michael K. Racke, MD. At the conclusion of this program, participants will be able to: Describe potential mechanisms for how SARS-CoV-2 enters the nervous system and affects cells, describe neurologic disorders secondary to ÐÓ°ÉÂÛ̳-19, including stroke and other neuroimmunological disorders, describe how ÐÓ°ÉÂÛ̳-19 affects clinical expression of other common comorbid neurological disorders. ASCLS P.A.C.E.? credits are available to laboratory professionals through May 18, 2021.

Author:

Racke, Michael K., MD
Medical Director of Neurology
Quest Diagnostics?

Our company

Quest? is the brand name used for services offered by ÐÓ°ÉÂÛ̳ and its affiliated companies. ÐÓ°ÉÂÛ̳ and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.? Other affiliates operated under the Quest? brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.?

?

Quest?, Quest Diagnostics?, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks¡ª? and ?¡ªare the property of their respective owners. ? 2025 ÐÓ°ÉÂÛ̳. All rights reserved. Image content features models and is intended for illustrative purposes only.